Search

Vascular access patients quality of life assessment

vascular access

“To identify studies that assess the quality of life of people with a peripheral intravenous catheter (PIVC), a midline catheter (MC) and a peripheral insertion central catheter (PICC)” Unanue-Arza et al (2025).

IV care impacted most by missed care opportunities – Full Text

iv complications

“The majority of reported missed care activities were from basic care domain followed by communication. The most common adverse events reported were intravenous infusion leaking into skin, intravenous fluid running dry, falls and development of pressure ulcer” Sarpong et al (2025).

How to reduce central line days – Full Text

central line

“Here we present a quality improvement initiative targeting CVC utilization via weekly physician-led audits and feedback of CVC necessity via text message conducted in a medical ICU (MICU)” Dekitani et al (2025).

Placement of totally implantable venous access devices in oncology practice – Full Text

iv port

“Despite the initial censure, his idea garnered interest across the Atlantic in the US, where Andre Counard and Dickinson Richards, in the 1940s, refined his technique and used it for cardiovascular research. In 1956, Forsmann, Counard and Richards were awarded the Nobel Prize in Physiology for their work on central venous access” Ong and Anil (2025).

Centrally inserted central catheter placement – Full Text

central line

“Automation of centrally inserted central catheters (CICCs) could potentially make CVAD placement safer, more effective, and more accessible. A new device that uses ultrasound image-guided, robotic needle placement, in addition to traditional Seldinger technique, to place a CICC is described” Herlihy et al (2025).

Malpositioning of central venous catheter – Full Text

central line

“This case is clinically significant, highlighting the potential for CVC malposition in the vertebral vein. It underscores the importance of careful monitoring during CVC insertion and removal, with particular attention to the potential for unexpected hemorrhagic events” Ito et al (2025).

Central venous catheter care training – Full Text

central line

“This study suggests the incorporation of central venous catheter care based on evidence-based guidelines into nursing curricula, postgraduate in-service training programs, and intensive care courses” İskender and Karadeniz (2025).

Implantable port and PICC comparison in breast cancer patients – Full Text

vascular access

“Previous investigations involving a mixed cancer population have shown a higher frequency of adverse events among patients receiving peripherally implanted central catheters (PICCs) compared with totally implanted central catheters (PORTs). Our study aimed to compare catheter-related adverse events in breast cancer patients” Utas et al (2025).

Data on medication waste in intensive care units – Full Text

Drug administration

“Discarded intravenous medication in the ICU is considerable and results in significant costs for the health care system, without obvious patient-centered value. Risk factors associated with medication waste were largely nonmodifiable, emphasizing the need for sustainable practices in patient care and resource management” d’Aranda et al 2025).

Potassium chloride solution extravasation injury – Full Text

extravasation

“The mixture of potassium chloride (10%, 50 mL) and sodium chloride (0.9%, 10 mL) was infused at a rate of 6 mL/h. However, the patient developed purplish swelling along the site of the cannula, which was not noted until half of the infusion was given” Ma and Wang (2025).

Arterial trauma due to central venous catheter insertion

IVTEAM Intravenous Literature

“Arterial trauma is a rare, but potentially life-threatening complication of central venous catheter insertion, with limited evidence to guide its prevention and management. We aimed to identify incidents from two national databases of incident reports to better characterise this complication and its consequences” Hart et al (2025).

Topical analgesia during needle-related procedures in children – Full Text

procedural pain

“We recommend the use of EMLA in children who need to undergo a minor needle-related procedure, with minimal application duration of 60 min (strong recommendation, very low-quality evidence). We suggest the use of tetracaine-containing creams only when rapid cannulation/puncture (ie, within 30-60 min) is required (weak recommendation, very low-quality evidence)” Stavleu et al (2025).

Preventing hemodialysis catheter dysfunction

central line

“Concentrated heparin lock (e.g., 5000 vs. 1000 IU/ml) have been associated with lower requirements for therapeutic CVC thrombolysis but increased systemic bleeding risks and costs. Citrate 4% was non-inferior to standard heparin locks to prevent thrombosis, may cause less bleeding, and is less costly in some countries” Lazarus et al (2025).

Hand motion tracking in central venous access

central line

“This study aims to compare a commercially available wired and wireless tracker in motion analysis of interventional radiologists performing simulated ultrasound-guided central venous access” Ali et al (2025).

Peripheral intravenous catheter needle flashback design

peripheral iv

“In this study, the authors found the insertion technique with grooved flashback needle design reduced operative error, double punctures and improved first-attempt success. This flashback needle design could significantly improve patient outcomes, speed time to treatment and reduce hospital costs” Moureau and Kaufman (2025).

Sterile transparent film IV dressing in newborns

iv dressing

“The use of a sterile transparent film dressing reduces tissue infiltration in neonates with peripheral intravenous catheters. It is recommended that health care professionals working in neonatal intensive care units use sterile transparent film dressings to dress peripheral intravenous catheters” Çalikuşu Incekar et al (2025).

Skin complications linked to vascular access devices

vascular access

“Cetuximab-based therapy is prone to develop skin complications. Our study aims to identify the impact on the central venous access by cetuximab-based therapy in patients with head and neck squamous cell carcinoma (HNSCC)” Huang et al (2025).

Innovative nanocoating for central venous catheters

central line

“In this study, CVCs coated with green and facile laccase-manganese phosphate hybrid nanostructures [(Mn3(PO4)2·HNSs] prevented bacterial adhesion by 100%, 80%, 60%, and 58% for Staphylococcus aureus, Staphylococcus epidermidis, Pseudomonas aeruginosa, and Escherichia coli, respectively” Golroudbari et al (2025).

Register for free citation alerts

Supporting your vascular access and infusion therapy learning journey